CEO

The approval was based on the petitioner's record of 5 peer-reviewed journal articles and 2 preprints in highly ranked journals. He demonstrated sustained acclaim through 54 citations, including a paper in the top 10% of its field, and 12 completed peer reviews for prestigious venues. Additionally, the petition showed major research funding and significant contributions to drug sensitivity prediction and robotic navigation.

Approval was based on the petitioner's extensive record of peer-reviewed conference papers and journal articles that garnered high citations from international researchers. He demonstrated extraordinary ability through his regular invitations to conduct peer reviews for authoritative journals and conferences. His work's practical applications in health databases and economical utility spending further satisfied the O-1 criteria.

The petition was approved based on a strong record of 7 peer-reviewed publications in top-tier venues like CVPR and ICCV, alongside 286 citations. The petitioner met the O-1A criteria through extensive peer review invitations for journals like IEEE T-PAMI and leadership roles in industry-standard benchmarking challenges. Evidence of international research funding from the European Research Council further solidified the claim of extraordinary ability.

The petition was approved based on the petitioner's 35 peer-reviewed publications and 1,078 citations, demonstrating significant impact in the field. Her 8 granted patents and their commercialization proved the real-world value of her technical achievements. Additionally, her service as a peer reviewer for prestigious journals 6 times satisfied the O-1 criteria for judging the work of others.